EASTHAM KARIN — SEC insider filings

SEC reporting owner CIK 1231845. 41 insider filings on record with FilingPulse; latest filed 2026-10-28.

Transaction summary — filings shown

Covers all 41 filings on record, filed 2020-09-24 to 2026-10-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERACYTE, INC. (VCYT)Director25—34 legs · 160,921 sh · $151,036,21528
NEKTAR THERAPEUTICS (NKTR)Director5—1 leg · 21,267 sh · $76,7748
Personalis, Inc. (PSNL)Director7——10
GERON CORP (GERN)Director4——6

Insider filings — EASTHAM KARIN

FiledFormIssuerReported transactionsSource
2026-10-284VERACYTE, INC. (VCYT)Option exercise (M): 10,000 @ $27.01 · Sale (S): 14,850 @ $50.00 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2026-06-224VERACYTE, INC. (VCYT)Sale (S): 3,200 @ $52.78 · Sale (S): 529 @ $53.55EDGAR
2026-06-154VERACYTE, INC. (VCYT)Grant/award (A): 5,272 @ $0EDGAR
2026-06-114/APersonalis, Inc. (PSNL)Grant/award (A): 6,250 @ $0EDGAR
2026-05-144Personalis, Inc. (PSNL)Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0EDGAR
2025-12-084VERACYTE, INC. (VCYT)Option exercise (M): 10,000 @ $7.94 · Option exercise (M): 10,000 @ $7.60 · Sale (S): 6,392 @ $44.52 · Sale (S): 12,808 @ $45.84 · Sale (S): 800 @ $46.59 · Option exercise (M): 10,000 (derivative) @ $0 · +1 moreEDGAR
2025-11-074VERACYTE, INC. (VCYT)Sale (S): 9,674 @ $40.02EDGAR
2025-06-234VERACYTE, INC. (VCYT)Grant/award (A): 9,321 @ $0EDGAR
2025-06-174VERACYTE, INC. (VCYT)Sale (S): 4,590 @ $26.66EDGAR
2025-05-204Personalis, Inc. (PSNL)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-01-064VERACYTE, INC. (VCYT)Option exercise (M): 10,000 @ $5.28 · Sale (S): 5,309 @ $40.12 · Sale (S): 4,691 @ $40.50 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2024-11-214VERACYTE, INC. (VCYT)Sale (S): 1,600 @ $36.77 · Sale (S): 3,006 @ $37.77 · Sale (S): 10,125 @ $38.76EDGAR
2024-07-184VERACYTE, INC. (VCYT)Sale (S): 7,500 @ $25EDGAR
2024-06-174VERACYTE, INC. (VCYT)Grant/award (A): 11,473 @ $0EDGAR
2024-06-134VERACYTE, INC. (VCYT)Sale (S): 3,870 @ $20.59EDGAR
2024-06-114VERACYTE, INC. (VCYT)Option exercise (M): 2,500 @ $10.41 · Sale (S): 2,500 @ $20.97 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2024-05-214Personalis, Inc. (PSNL)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-04-024VERACYTE, INC. (VCYT)Option exercise (M): 10,000 @ $13.19 · Sale (S): 10,000 @ $21.65 · Option exercise (M): 10,000 (derivative) @ $13.19EDGAR
2023-06-134VERACYTE, INC. (VCYT)Grant/award (A): 9,674 @ $0EDGAR
2023-05-194Personalis, Inc. (PSNL)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-03-174VERACYTE, INC. (VCYT)Option exercise (M): 18,750 @ $12.12 · Sale (S): 18,750 @ $22.78 · Option exercise (M): 18,750 (derivative) @ $0EDGAR
2023-03-024VERACYTE, INC. (VCYT)Option exercise (M): 10,000 @ $12.12 · Sale (S): 10,000 @ $25.00 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-01-174GERON CORP (GERN)Option exercise (M): 35,000 @ $1.10 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2022-09-204NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 10,200 @ $0 · Grant/award (A): 20,400 (derivative) @ $0EDGAR
2022-09-144NEKTAR THERAPEUTICS (NKTR)Sale (S): 21,267 @ $3.61EDGAR
2022-06-164VERACYTE, INC. (VCYT)Grant/award (A): 14,731 @ $0EDGAR
2022-05-194Personalis, Inc. (PSNL)Grant/award (A): 10,770 @ $0 · Grant/award (A): 15,035 (derivative) @ $0EDGAR
2022-05-114GERON CORP (GERN)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-04-214GERON CORP (GERN)Option exercise (M): 35,000 @ $1.41 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2021-12-204VERACYTE, INC. (VCYT)Option exercise (M): 5,000 @ $12.12 · Sale (S): 5,000 @ $45 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2021-11-034VERACYTE, INC. (VCYT)Sale (S): 200 @ $47.73 · Sale (S): 2,959 @ $49,015 · Sale (S): 1,241 @ $49.48EDGAR
2021-09-244NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 10,200 @ $0 · Grant/award (A): 20,400 (derivative) @ $0EDGAR
2021-08-044VERACYTE, INC. (VCYT)Sale (S): 2,846 @ $43.54 · Sale (S): 1,554 @ $44.57EDGAR
2021-06-104VERACYTE, INC. (VCYT)Grant/award (A): 8,720 @ $0EDGAR
2021-05-184Personalis, Inc. (PSNL)Grant/award (A): 2,736 @ $0 · Grant/award (A): 4,229 (derivative) @ $0EDGAR
2021-05-134GERON CORP (GERN)Grant/award (A): 83,000 (derivative) @ $0EDGAR
2021-05-054/AVERACYTE, INC. (VCYT)Option exercise (M): 6,250 @ $4 · Sale (S): 2,444 @ $60.03 · Sale (S): 3,606 @ $61.09 · Sale (S): 200 @ $61.77 · Option exercise (M): 6,250 (derivative) @ $0EDGAR
2021-05-054VERACYTE, INC. (VCYT)Sale (S): 3,527 @ $48.01 · Sale (S): 650 @ $49.00 · Sale (S): 250 @ $50.03EDGAR
2021-02-264VERACYTE, INC. (VCYT)Option exercise (M): 6,250 @ $4 · Sale (S): 2,444 @ $60.03 · Sale (S): 3,606 @ $61.09 · Sale (S): 200 @ $61.77 · Option exercise (M): 6,250 (derivative) @ $0EDGAR
2020-09-254/ANEKTAR THERAPEUTICS (NKTR)Grant/award (A): 9,100 @ $0 · Grant/award (A): 18,200 (derivative) @ $0EDGAR
2020-09-244NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 9,100 @ $0 · Grant/award (A): 18,200 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-24 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1231845 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs